Cost to the CCG and/or the Area Team What is the bottom line for the CCG and/or Area Team by This is critical to assist with financial decision financial year making and planning 2013/14 part year costs: £15 000 – 2014/15 full year costs: £30 000 – 2015/16 full year £30 000 – Breakdown of ETCs requested. What is What are the drug costs or costs of clinical staff time e.g. 0.4 wte The Directors want to see that the costs are included within the cost? Band 6 physiotherapist for 18 months. appropriate This can be presented as per patient cost recruited, but a breakdown of how this has been calculated is required. If the are being incurred by a provider Information should include a summary of discussions held at the This will demonstrate that local discussions within Trust (i.e. not in primary care) then justification provider and who has been involved in the decision making. the Provider Trust have been held with the is required as to why the provider Trust can’t relevant individuals e.g. Clinical Director / R&D Can the provider trust part fund the ETCs to share the costs? fund the ETCs. Director / Director of Finance / Director of Contracting, Business Development etc Any other relevant information For example information on value for money (VFM) in relation to the study intervention. Notes for applicants: R&D teams supporting commissioning organisations may require additional information eg fit with local strategic priorities. Please liaise with the relevant R&D team for advice Excess treatment costs are funded through the normal arrangements for commissioning patient care Please liaise with the relevant R&D Manager in the first instance about invoicing arrangements for approved ETCs As from 1st April 2013:
Cost to the CCG and/or the Area Team What is the bottom line for the CCG and/or Area Team by financial year 2013/14 – part year costs: £15 000 2014/15 – full year costs: £30 000 2015/16 – full year £30 000 This is critical to assist with financial decision making and planning Breakdown of ETCs requested. What is included within the cost? What are the drug costs or costs of clinical staff time e.g. 0.4 wte Band 6 physiotherapist for 18 months. This can be presented as per patient cost recruited, but a breakdown of how this has been calculated is required. The Directors want to see that the costs are appropriate If the are being incurred by a provider Trust (i.e. not in primary care) then justification is required as to why the provider Trust can’t fund the ETCs. Information should include a summary of discussions held at the provider and who has been involved in the decision making. Can the provider trust part fund the ETCs to share the costs? This will demonstrate that local discussions within the Provider Trust have been held with the relevant individuals e.g. Clinical Director / R&D Director / Director of Finance / Director of Contracting, Business Development etc Any other relevant information For example information on value for money (VFM) in relation to the study intervention. Notes for applicants: R&D teams supporting commissioning organisations may require additional information eg fit with local strategic priorities. Please liaise with the relevant R&D team for advice Excess treatment costs are funded through the normal arrangements for commissioning patient care Please liaise with the relevant R&D Manager in the first instance about invoicing arrangements for approved ETCs As from 1st April 2013:
RevisedETCAug2013.docx